COMMUNIQUÉS West-GlobeNewswire

-
Marrone Bio Innovations to Attend Upcoming Investor Conferences in May
01/05/2019 -
Yield10 Bioscience to Announce First Quarter 2019 Financial Results and Host a Conference Call on Thursday, May 9, 2019
01/05/2019 -
Eyenovia Announces Conference Call and Webcast for First Quarter 2019 Financial Results
01/05/2019 -
Allogene Therapeutics Announces Expansion of Scientific Advisory Board
01/05/2019 -
L-DOS47 Phase II Randomized Study Advances to Second Cohort
01/05/2019 -
Zogenix to Release First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 8
01/05/2019 -
Tyme Technologies to Participate at the SunTrust Robinson Humphrey 5th Annual Life Sciences Summit on May 7th
01/05/2019 -
Jounce Therapeutics to Announce First Quarter 2019 Financial Results and Host Conference Call on Wednesday, May 8, 2019
01/05/2019 -
Todos Medical Receives Notice of Allowance from the USPTO Covering the Early Diagnosis of Lung Cancer Using the Todos Biochemical Infrared Analysis (TBIA)
01/05/2019 -
Abeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM™ Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual Meeting
01/05/2019 -
VBI Vaccines Announces First Quarter 2019 Financial Results and Provides Corporate Update
01/05/2019 -
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2019 -
IntelGenx Announces Issuance of Second U.S. Patent for Topical Oral Film Technology
01/05/2019 -
Phoenix Life Announces $40 Million Capital Raise in Conjunction with TABOR Family Office Conference
01/05/2019 -
Tauriga Sciences, Inc. Enters into Distribution Agreement Focused on Tauri-Gum Sales Throughout Northeast Region of USA and Asia
01/05/2019 -
Adaptimmune to Provide Clinical and Business Update on Monday May 6th, 2019
01/05/2019 -
Xeris Pharmaceuticals Announces Results From a Phase 1 Study of Its Novel Formulation of Diazepam
01/05/2019 -
Stryker declares a $0.52 per share quarterly dividend
01/05/2019 -
Abeona Therapeutics présente des données précliniques démontrant un large potentiel thérapeutique de la thérapie génique AIM™ dans les maladies rétiniennes lors de l'assemblée générale annuelle de l'Association for Research in Vision and Ophthalmology
01/05/2019
Pages